Accelerated Burn Healing in a Mouse Experimental Model Using α-Gal Nanoparticles
Abstract
:1. Introduction
2. Anti-Gal and the α-Gal Epitope
3. Hypothesis
4. Experimental Animal Models
5. In Vitro Effects of α-Gal Nanoparticles on Macrophages
6. In Vivo Effects of α-Gal Nanoparticles on Macrophages
7. Macrophages Recruited by α-Gal Nanoparticles Are M2 Further Recruiting MSCs
8. Accelerated Healing of Burns by Topical Application of α-Gal Nanoparticles
9. α-Gal Nanoparticles Mediated Accelerated Healing of Wounds
10. Concluding Remarks
Funding
Conflicts of Interest
References
- Mahdavian Delavary, B.; van der Veer, W.M.; van Egmond, M.; Niessen, F.B.; Beelen, R.H. Macrophages in skin injury and repair. Immunobiology 2011, 216, 753–762. [Google Scholar] [CrossRef] [PubMed]
- DiPietro, L.A.; Koh, T.J. Macrophages and wound healing. Adv. Wound Care 2016, 2, 71–75. [Google Scholar]
- Suda, S.; Williams, H.; Medbury, H.J.; Holland., A.J. A Review of Monocytes and Monocyte-Derived Cells in Hypertrophic Scarring Post Burn. J. Burn Care Res. 2016, 37, 265–272. [Google Scholar] [CrossRef] [PubMed]
- Penatzer, J.A.; Srinivas, S.; Thakkar, R.K. The role of macrophages in thermal injury. Int. J. Burns Trauma. 2022, 12, 1–12. [Google Scholar]
- Italiani, P.; Boraschi, D. From Monocytes to M1/M2 macrophages: Phenotypical vs. functional differentiation. Front. Immunol. 2014, 5, 514. [Google Scholar] [CrossRef]
- Singer, A.J.; Clark, R.A. Cutaneous wound healing. N. Engl. J. Med. 1999, 341, 738–746. [Google Scholar] [CrossRef]
- Jeschke, M.G.; van Baar, M.E.; Choudhry, M.A.; Chung, K.K.; Gibran, N.S.; Logsetty, S. Burn injury. Nat. Rev. Dis. Primer. 2020, 6, 11. [Google Scholar] [CrossRef]
- Piccolo, M.T.; Wang, Y.; Sannomiya, P.; Piccolo, N.S.; Piccolo, M.S.; Hugli, T.E.; Ward, P.A.; Till, G.O. Chemotactic mediator requirements in lung injury following skin burns in rats. Exp. Mol. Pathol. 1999, 66, 220–226. [Google Scholar] [CrossRef]
- Shukaliak, J.; Dorovini-Zis, K. Expression of the [β]-Chemokines RANTES and MIP-1β by Human Brain Microvessel Endothelial Cells in Primary Culture. J. Neuropathol. Exp. Neurol. 2000, 59, 339–352. [Google Scholar] [CrossRef]
- Shallo, H.; Plackett, T.P.; Heinrich, S.A.; Kovacs, E.J. Monocyte chemoattractant protein-1 (MCP-1) and macrophage infiltration into the skin after burn injury in aged mice. Burns 2003, 29, 641–647. [Google Scholar] [CrossRef]
- Heinrich, S.A.; Messingham, K.A.; Gregory, M.S.; Colantoni, A.; Ferreira, A.M.; Dipietro, L.A.; Kovacs, E.J. Elevated monocyte chemoattractant protein-1 levels following thermal injury precede monocyte recruitment to the wound site and are controlled, in part, by tumor necrosis factor-α. Wound Repair Regen. 2003, 11, 110–119. [Google Scholar] [CrossRef] [PubMed]
- Tyler, M.P.; Watts, A.M.; Perry, M.E.; Roberts, A.H.; McGrouther, D.A. Dermal cellular inflammation in burns. An insight into the function of dermal microvascular anatomy. Burns 2001, 27, 433–438. [Google Scholar] [CrossRef] [PubMed]
- Martin, P.; Leibovich, S.J. Inflammatory cells during wound repair: The good, the bad and the ugly. Trends Cell Biol. 2005, 15, 599–607. [Google Scholar] [CrossRef]
- Franz, M.G.; Steed, D.L.; Robson, M.C. Optimizing healing of the acute wound by minimizing complications. Curr. Probl. Surg. 2007, 4, 691–763. [Google Scholar] [CrossRef] [PubMed]
- Alexander, M.; Chaudry, I.H.; Schwacha, M.G. Relationships between burn size, immunosuppression, and macrophage hyperactivity in a murine model of thermal injury. Cell. Immunol. 2002, 220, 63–69. [Google Scholar] [CrossRef] [PubMed]
- Schwacha, M.G. Macrophages and post-burn immune dysfunction. Burns 2003, 29, 1–14. [Google Scholar] [CrossRef]
- Galili, U.; Wigglesworth, K.; Abdel-Motal, U.M. Accelerated healing of skin burns by anti-Gal/α-gal liposomes interaction. Burns 2010, 36, 239–251. [Google Scholar] [CrossRef]
- Galili, U. α-Gal Nanoparticles in Wound and Burn Healing Acceleration. Adv. Wound Care 2017, 6, 81–92. [Google Scholar] [CrossRef]
- Hocking, A.M. Mesenchymal Stem Cell Therapy for Cutaneous Wounds. Adv. Wound Care 2012, 1, 166–171. [Google Scholar] [CrossRef]
- Jo, H.; Brito, S.; Kwak, B.M.; Park, S.; Lee, M.G.; Bin, B.H. Applications of Mesenchymal Stem Cells in Skin Regeneration and Rejuvenation. Int. J. Mol. Sci. 2021, 22, 2410. [Google Scholar] [CrossRef]
- Hernon, C.A.; Dawson, R.A.; Freedlander, E.; Short, R.; Haddow, D.B.; Brotherston, M.; MacNeil, S. Clinical experience using cultured epithelial autografts leads to an alternative methodology for transferring skin cells from the laboratory to the patient. Regen. Med. 2006, 1, 809–821. [Google Scholar] [CrossRef] [PubMed]
- Lee, H. Outcomes of sprayed cultured epithelial autografts for full-thickness wounds: A single-centre experience. Burns 2012, 38, 931–936. [Google Scholar] [CrossRef] [PubMed]
- Yuan, L.; Minghua, C.; Feifei, D.; Runxiu, W.; Ziqiang, L.; Chengyue, M.; Wenbo, J. Study of the use of recombinant human granulocyte-macrophage colony-stimulating factor hydrogel externally to treat residual wounds of extensive deep partial-thickness burn. Burns 2015, 41, 1086–1091. [Google Scholar] [CrossRef] [PubMed]
- Yan, D.; Liu, S.; Zhao, X.; Bian, H.; Yao, X.; Xing, J.; Sun, W.; Chen, X. Recombinant human granulocyte macrophage colony stimulating factor in deep second-degree burn wound healing. Medicine 2017, 96, e6881. [Google Scholar] [CrossRef]
- Lavker, R.M.; Kaplan, N.; McMahon, K.M.; Calvert, A.E.; Henrich, S.E.; Onay, U.V.; Lu, K.Q.; Peng, H.; Thaxton, C.S. Synthetic high-density lipoprotein nanoparticles: Good things in small packages. Ocul. Surf. 2021, 21, 19–26. [Google Scholar] [CrossRef] [PubMed]
- Hermosilla, J.; Pastene-Navarrete, E.; Acevedo, F. Electrospun Fibers Loaded with Natural Bioactive Compounds as a Biomedical System for Skin Burn Treatment. A Review. Pharmaceutics 2021, 13, 2054. [Google Scholar] [CrossRef]
- Weng, T.; Wang, J.; Yang, M.; Zhang, W.; Wu, P.; You, C.; Han, C.; Wang, X. Nanomaterials for the delivery of bioactive factors to enhance angiogenesis of dermal substitutes during wound healing. Burns Trauma 2022, 10, tkab049. [Google Scholar] [CrossRef]
- Frear, C.C.; Griffin, B.R.; Cuttle, L.; Kimble, R.M.; McPhail, S.M. Cost-effectiveness of adjunctive negative pressure wound therapy in pediatric burn care: Evidence from the SONATA in C randomized controlled trial. Sci. Rep. 2021, 11, 16650. [Google Scholar] [CrossRef]
- Galili, U.; Rachmilewitz, E.A.; Peleg, A.; Flechner, I. A unique natural human IgG antibody with anti-α-galactosyl specificity. J. Exp. Med. 1984, 160, 1519–1531. [Google Scholar] [CrossRef]
- Galili, U.; Mandrell, R.E.; Hamadeh, R.M.; Shohet, S.B.; Griffiss, J.M. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect. Immun. 1988, 56, 1730–1737. [Google Scholar] [CrossRef]
- Mañez, R.; Blanco, F.J.; Díaz, I.; Centeno, A.; Lopez-Pelaez, E.; Hermida, M.; Davies, H.F.; Katopodis, A. Removal of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural α-galactosyl IgG antibodies. Xenotransplantation 2001, 8, 15–23. [Google Scholar] [CrossRef] [PubMed]
- Galili, U.; Macher, B.A.; Buehler, J.; Shohet, S.B. Human natural anti-α-galactosyl IgG. II. The specific recognition of α[1,3]-linked galactose residues. J. Exp. Med. 1985, 162, 573–582. [Google Scholar] [CrossRef] [PubMed]
- Towbin, H.; Rosenfelder, G.; Wieslander, J.; Avila, J.L.; Rojas, M.; Szarfman, A.; Esser, K.; Nowack, H.; Timpl, R. Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl [α1-3]-galactose epitopes. J. Exp. Med. 1987, 166, 419–432. [Google Scholar] [CrossRef] [PubMed]
- Teneberg, S.; Lönnroth, I.; Torres Lopez, J.F.; Galili, U.; Olwegard Halvarsson, M.; Angstrom, J.; Karlsson, K.A. Molecular mimicry in the recognition of glycosphingolipids by Galα3Galß4GlcNAcß-binding Clostridium difficile toxin A, human natural anti-α-galactosyl IgG and the monoclonal antibody Gal-13: Characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor. Glycobiology 1996, 6, 599–609. [Google Scholar] [PubMed]
- Galili, U.; Clark, M.R.; Shohet, S.B.; Buehler, J.; Macher, B.A. Evolutionary relationship between the anti-Gal antibody and the Galα1-3Gal epitope in primates. Proc. Natl. Acad. Sci. USA 1987, 84, 1369–1373. [Google Scholar] [CrossRef]
- Galili, U.; Shohet, S.B.; Kobrin, E.; Stults, C.L.M.; Macher, B.A. Man, apes, and Old-World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J. Biol. Chem. 1988, 263, 17755–17762. [Google Scholar] [CrossRef]
- Thall, A.; Galili, U. Distribution of Gal alpha 1→3Gal beta 1→4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay. Biochemistry 1990, 29, 3959–3965. [Google Scholar] [CrossRef]
- Oriol, R.; Candelier, J.J.; Taniguchi, S.; Balanzino, L.; Peters, L.; Niekrasz, M.; Hammer, C.; Cooper, D.K. Major carbohydrate epitopes in tissues of domestic and African wild animals of potential interest for xenotransplantation research. Xenotransplantation 1999, 6, 79–89. [Google Scholar] [CrossRef]
- Cooper, D.K.C.; Good, A.H.; Koren, E.; Oriol, R.; Malcolm, A.J.; Ippolito, R.M.; Neethling, F.A.; Ye, Y.; Romano, E.; Zuhdi, N. Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: Relevance to discordant xenografting in man. Transpl. Immunol. 1993, 1, 198–205. [Google Scholar] [CrossRef]
- Galili, U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: A major obstacle for xenotransplantation in humans. Immunol. Today 1993, 14, 480–482. [Google Scholar] [CrossRef]
- Sandrin, M.S.; Vaughan, H.A.; Dabkowski, P.L.; McKenzie, I.F.C. Anti-pig IgM antibodies in human serum react predominantly with Gal (αl-3)Gal epitopes. Proc. Natl. Acad. Sci. USA 1993, 90, 11391–11395. [Google Scholar] [CrossRef] [PubMed]
- Collins, B.H.; Cotterell, A.H.; McCurry, K.R.; Alvarado, C.G.; Magee, J.C.; Parker, W.; Platt, J.L. Cardiac xenografts between primate species provide evidence for the importance of the α-galactosyl. determinant in hyperacute rejection. J. Immunol. 1995, 154, 5500–5510. [Google Scholar] [CrossRef] [PubMed]
- Repik, P.M.; Strizki, M.; Galili, U. Differential host dependent expression of α-galactosyl epitopes on viral glycoproteins: A study of Eastern equine encephalitis virus as a model. J. Gen. Virol. 1994, 75, 1177–1181. [Google Scholar] [CrossRef]
- Pipperger, L.; Koske, I.; Wild, N.; Müllauer, B.; Krenn, D.; Stoiber, H.; Wollmann, G.; Kimpel, J.; von Laer, D.; Bánki, Z. Xenoantigen-dependent complement-mediated neutralization of LCMV glycoprotein pseudotyped VSV in human serum. J. Virol. 2019, 93, e00567-19. [Google Scholar] [CrossRef] [PubMed]
- Takeuchi, Y.; Porter, C.D.; Strahan, K.M.; Preece, A.F.; Gustafsson, K.; Cosset, F.L.; Weiss, R.A.; Collins, M.K. Sensitization of cells and retroviruses to human serum by [α1-3] galactosyltransferase. Nature 1996, 379, 85–88. [Google Scholar] [CrossRef] [PubMed]
- Preece, A.F.; Strahan, K.M.; Devitt, J.; Yamamoto, F.; Gustafsson, K. Expression of ABO or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement. Blood 2002, 99, 2477–2482. [Google Scholar] [CrossRef] [PubMed]
- Galili, U. The Natural Anti-Gal Antibody as Foe Turned Friend in Medicine; Academic Press: London, UK; Elsevier: New York, NY, USA, 2018; pp. 207–228. [Google Scholar]
- Wigglesworth, K.M.; Racki, W.J.; Mishra, R.; Szomolanyi-Tsuda, E.; Greiner, D.L.; Galili, U. Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healing. J. Immunol. 2011, 186, 4422–4432. [Google Scholar] [CrossRef]
- Thall, A.D.; Maly, P.; Lowe, J.B. Oocyte Galα,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J. Biol. Chem. 1995, 270, 21437–21440. [Google Scholar] [CrossRef]
- Tearle, R.G.; Tange, M.J.; Zanettino, Z.L.; Katerelos, M.; Shinkel, T.A.; Van Denderen, B.J.; Lonie, A.J.; Lyonsm, I.; Nottle, M.B.; Cox, T.; et al. The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation. Transplantation 1996, 61, 13–19. [Google Scholar] [CrossRef]
- Lai, L.; Kolber-Simonds, D.; Park, K.W.; Cheong, H.T.; Greenstein, J.L.; Im, G.S.; Samuel, M.; Bonk, A.; Rieke, A.; Day, B.N.; et al. Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002, 295, 1089–1092. [Google Scholar] [CrossRef]
- Phelps, C.J.; Koike, C.; Vaught, T.D.; Boone, J.; Wells, K.D.; Chen, S.H.; Ball, S.; Specht, S.M.; Polejaeva, I.A.; Monahan, J.A.; et al. Production of α1,3-galactosyltransferase-deficient pigs. Science 2003, 299, 411–414. [Google Scholar] [CrossRef] [PubMed]
- Dor, F.J.; Tseng, Y.L.; Cheng, J.; Moran, K.; Sanderson, T.M.; Lancos, C.J.; Shimizu, A.; Yamada, K.; Awwad, M.; Sachs, D.H.; et al. α1,3-Galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-Gal antibodies. Transplantation 2004, 78, 15–20. [Google Scholar] [CrossRef] [PubMed]
- Fang, J.; Walters, A.; Hara, H.; Long, C.; Yeh, P.; Ayares, D.; Cooper, D.K.; Bianchi, J. Anti-gal antibodies in α1,3-galactosyltransferase gene knockout pigs. Xenotransplantation 2012, 19, 305–310. [Google Scholar] [CrossRef] [PubMed]
- Galili, U. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates. Xenotransplantation 2013, 20, 267–276. [Google Scholar] [CrossRef]
- Tanemura, M.; Yin, D.; Chong, A.S.; Galili, U. Differential immune responses to α-gal epitopes on xenografts and allografts: Implications for accommodation in xenotransplantation. J. Clin. Investig. 2000, 105, 301–310. [Google Scholar] [CrossRef]
- Galili, U.; Goldufsky, J.W.; Schaer, G.L. α-Gal Nanoparticles Mediated Homing of Endogenous Stem Cells for Repair and Regeneration of External and Internal Injuries by Localized Complement Activation and Macrophage Recruitment. Int. J. Mol. Sci. 2022, 23, 11490. [Google Scholar] [CrossRef]
- Kaymakcalan, O.E.; Abadeer, A.; Goldufsky, J.W.; Galili, U.; Karinja, S.J.; Dong, X.; Jin, J.L.; Samadi, A.; Spector, J.A. Topical α-gal nanoparticles accelerate diabetic wound healing. Exp. Dermatol. 2020, 29, 404–413. [Google Scholar] [CrossRef]
- Kaymakcalan, O.E.; Karinja, S.; Abadeer, A.; Dong, X.; Jin, J.L.; Galili, U.; Spector, J.A. Antigen-Mediated, Macrophage-Stimulated, Accelerated Wound Healing Using α-Gal Nanoparticles. Ann. Plast. Surg. 2018, 80 (Suppl. 4), S196–S203. [Google Scholar] [CrossRef]
- Samadi, A.; Buro, J.; Dong, X.; Weinstein, A.; Lara, D.O.; Celie, K.B.; Wright, M.A.; Gadijko, M.A.; Galili, U.; Spector, J.A. Topical α-Gal Nanoparticles Enhance Wound Healing in Radiated Skin. Ski. Pharmacol. Physiol. 2022, 35, 31–40. [Google Scholar] [CrossRef]
- Galili, U.; Zhu, Z.; Chen, J.; Goldufsky, J.W.; Schaer, G.L. Near Complete Repair after Myocardial Infarction in Adult Mice by Altering the Inflammatory Response with Intramyocardial Injection of α-Gal Nanoparticles. Front. Cardiovasc. Med. 2021, 8, 719160. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Galili, U. Accelerated Burn Healing in a Mouse Experimental Model Using α-Gal Nanoparticles. Bioengineering 2023, 10, 1165. https://doi.org/10.3390/bioengineering10101165
Galili U. Accelerated Burn Healing in a Mouse Experimental Model Using α-Gal Nanoparticles. Bioengineering. 2023; 10(10):1165. https://doi.org/10.3390/bioengineering10101165
Chicago/Turabian StyleGalili, Uri. 2023. "Accelerated Burn Healing in a Mouse Experimental Model Using α-Gal Nanoparticles" Bioengineering 10, no. 10: 1165. https://doi.org/10.3390/bioengineering10101165